Validate Tests News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Twist Bioscience Corporation: Twist Bioscience to Offer Synthetic RNA Control for UK Variant Strain of SARS-CoV-2
Controls to be Used to Develop, Verify and Validate Tests that Identify More Transmissible Variant
Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced plans to offer a new synthetic RNA control that includes the new variant of SARS-CoV-2 circulating in the United Kingdom and South Africa. This new variant strain of SARS-CoV-2 contains multiple spike protein mutations as well as mutations in other areas of the viral genome. ....

South Africa , United Kingdom , Emilym Leproust , Facebook Linkedin Youtube , Exchange Commission On , European Centers For Disease , Drug Administration , Twist Bioscience Corporation Nasdaq , Corporate Affairs , Twist Bioscience Corporation , May Increase , Validate Tests , Identify More Transmissible , Bioscience Corporation , European Centers , Disease Control , Twitter Facebook Linkedin Youtube , Private Securities Litigation Reform Act , Twist Bioscience , Quarterly Report Form , Exchange Commission , ஒன்றுபட்டது கிஂக்டம் , முகநூல் சென்டர் வலைஒளி , பரிமாற்றம் தரகு ஆன் , ஐரோப்பிய மையங்கள் க்கு நோய் , திருப்பம் உயிர் அறிவியல் நிறுவனம் நாஸ்டாக் ,